{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "11",
                "@year": "2022",
                "@timestamp": "2022-03-11T12:51:24.000024-05:00",
                "@month": "03"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2022",
                "@month": "12"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {
                    "xocs:funding-agency-matched-string": "Chulalongkorn Academic Advancement",
                    "xocs:funding-id": "64-106"
                },
                {"xocs:funding-agency-matched-string": "Ratchadapiseksompotch Fund"},
                {
                    "xocs:funding-agency-matched-string": "Chulalongkorn University",
                    "xocs:funding-agency-acronym": "CU",
                    "xocs:funding-agency": "Chulalongkorn University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Faculty of Medicine, Chulalongkorn University",
                    "xocs:funding-agency": "Faculty of Medicine, Chulalongkorn University",
                    "xocs:funding-id": "RA60/121",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004776",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2022-02-22T05:58:00.743Z",
            "xocs:funding-text": "This research was supported by the Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University (Grant number RA60/121) to CV, Chulalongkorn Academic Advancement into Its 2nd Century (CUAASC) Project to VS and Health Systems Research Institute (Thailand) (Grant number 64-106) to CV. Biospecimen collection was supported by Biobank, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. The authors would like to thank Dr. Harit Suwanrusme for critical review of the manuscript.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10330",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University and The King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60022183",
                                    "@dptid": "100291259"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2015001130-b887ce3207d06414860e54b2a5f2e22f",
                            "ce:source-text": "Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand",
                            "@dptid": "100291259"
                        },
                        "author": [
                            {
                                "ce:given-name": "Piyada",
                                "preferred-name": {
                                    "ce:given-name": "Piyada",
                                    "ce:initials": "P.",
                                    "ce:surname": "Sitthideatphaiboon",
                                    "ce:indexed-name": "Sitthideatphaiboon P."
                                },
                                "@seq": "1",
                                "@author-instance-id": "2015001130-aa43f43d7b04d6459a7742278aff399f",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sitthideatphaiboon",
                                "@auid": "57192833487",
                                "ce:indexed-name": "Sitthideatphaiboon P."
                            },
                            {
                                "ce:given-name": "Virote",
                                "preferred-name": {
                                    "ce:given-name": "Virote",
                                    "ce:initials": "V.",
                                    "ce:surname": "Sriuranpong",
                                    "ce:indexed-name": "Sriuranpong V."
                                },
                                "@seq": "11",
                                "@author-instance-id": "2015001130-189d64ff017fa588daae77f69c08b228",
                                "ce:initials": "V.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sriuranpong",
                                "@auid": "6603599644",
                                "ce:indexed-name": "Sriuranpong V."
                            },
                            {
                                "ce:given-name": "Chanida",
                                "preferred-name": {
                                    "ce:given-name": "Chanida",
                                    "ce:initials": "C.",
                                    "ce:surname": "Vinayanuwattikun",
                                    "ce:indexed-name": "Vinayanuwattikun C."
                                },
                                "@seq": "12",
                                "@author-instance-id": "2015001130-b4d1f2f3ff87cebc1f7e9d9a47c6ab68",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Vinayanuwattikun",
                                "@auid": "54390216800",
                                "ce:indexed-name": "Vinayanuwattikun C."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10330",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Chula GenePRO Center"},
                                {"$": "Research Affairs"},
                                {"$": "Chulalongkorn University and The King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60022183",
                                    "@dptid": "127689321"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2015001130-a4cdc183bfbf663e448973ceece3fc71",
                            "ce:source-text": "Chula GenePRO Center, Research Affairs, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand",
                            "@dptid": "127689321"
                        },
                        "author": [
                            {
                                "ce:given-name": "Chinachote",
                                "preferred-name": {
                                    "ce:given-name": "Chinachote",
                                    "ce:initials": "C.",
                                    "ce:surname": "Teerapakpinyo",
                                    "ce:indexed-name": "Teerapakpinyo C."
                                },
                                "@seq": "2",
                                "@author-instance-id": "2015001130-ec30645a7d0a084680b7fb197c79b1ec",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Teerapakpinyo",
                                "@auid": "56653456600",
                                "ce:indexed-name": "Teerapakpinyo C."
                            },
                            {
                                "ce:given-name": "Shanop",
                                "preferred-name": {
                                    "ce:given-name": "Shanop",
                                    "ce:initials": "S.",
                                    "ce:surname": "Shuangshoti",
                                    "ce:indexed-name": "Shuangshoti S."
                                },
                                "@seq": "8",
                                "@author-instance-id": "2015001130-6997bd27a234bd19691c013f993e6726",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Shuangshoti",
                                "@auid": "55063064300",
                                "ce:indexed-name": "Shuangshoti S."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "address-part": "Siriraj, Bangkok Noi",
                            "postal-code": "10700",
                            "@afid": "60199575",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine Siriraj Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199575",
                                    "@dptid": "125758157"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "2015001130-cae6dced10ab8b5caabc2425cc66cf2d",
                            "ce:source-text": "Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Siriraj, Bangkok Noi, Bangkok, 10700, Thailand",
                            "@dptid": "125758157"
                        },
                        "author": [{
                            "ce:given-name": "Krittiya",
                            "preferred-name": {
                                "ce:given-name": "Krittiya",
                                "ce:initials": "K.",
                                "ce:surname": "Korphaisarn",
                                "ce:indexed-name": "Korphaisarn K."
                            },
                            "@seq": "3",
                            "@author-instance-id": "2015001130-15648c8fb5ed515c6184bcaabfb8dbd9",
                            "ce:initials": "K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Korphaisarn",
                            "@auid": "56461382100",
                            "ce:indexed-name": "Korphaisarn K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Pulmonary and Critical Care Medicine"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University and The King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60022183",
                                    "@dptid": "100291259"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2015001130-7110f8b2ac5ec50cf3ffa757cf013b02",
                            "ce:source-text": "Division of Pulmonary and Critical Care Medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, Thailand",
                            "@dptid": "100291259"
                        },
                        "author": [{
                            "ce:given-name": "Nophol",
                            "preferred-name": {
                                "ce:given-name": "Nophol",
                                "ce:initials": "N.",
                                "ce:surname": "Leelayuwatanakul",
                                "ce:indexed-name": "Leelayuwatanakul N."
                            },
                            "@seq": "4",
                            "@author-instance-id": "2015001130-0bf7faeef92956067d2be07169ab153a",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Leelayuwatanakul",
                            "@auid": "57201374781",
                            "ce:indexed-name": "Leelayuwatanakul N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10330",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Surgery"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University and The King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60022183",
                                    "@dptid": "104136198"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2015001130-eba0de20022f5ca8c7ee0e6140c17c62",
                            "ce:source-text": "Department of Surgery, Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand",
                            "@dptid": "104136198"
                        },
                        "author": [{
                            "ce:given-name": "Nopporn",
                            "preferred-name": {
                                "ce:given-name": "Nopporn",
                                "ce:initials": "N.",
                                "ce:surname": "Pornpatrananrak",
                                "ce:indexed-name": "Pornpatrananrak N."
                            },
                            "@seq": "5",
                            "@author-instance-id": "2015001130-668662f89cde347a221108f25be7cdd1",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Pornpatrananrak",
                            "@auid": "57446072500",
                            "ce:indexed-name": "Pornpatrananrak N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "address-part": "Siriraj, Bangkok Noi",
                            "postal-code": "10700",
                            "@afid": "60199575",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Clinical Pathology"},
                                {"$": "Faculty of Medicine Siriraj Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199575",
                                    "@dptid": "125771064"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "2015001130-88313bf37fd3f2e2c1fe126bc888426f",
                            "ce:source-text": "Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Siriraj, Bangkok Noi, Bangkok, 10700, Thailand",
                            "@dptid": "125771064"
                        },
                        "author": [{
                            "ce:given-name": "Naravat",
                            "preferred-name": {
                                "ce:given-name": "Naravat",
                                "ce:initials": "N.",
                                "ce:surname": "Poungvarin",
                                "ce:indexed-name": "Poungvarin N."
                            },
                            "@seq": "6",
                            "@author-instance-id": "2015001130-01c958298f5b86eb467951d344dd1b76",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Poungvarin",
                            "@auid": "7005666704",
                            "ce:indexed-name": "Poungvarin N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10330",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Pathology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University and The King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60022183",
                                    "@dptid": "104136206"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2015001130-d40631eaaf2248611ff17a702adecd22",
                            "ce:source-text": "Department of Pathology, Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand",
                            "@dptid": "104136206"
                        },
                        "author": [
                            {
                                "ce:given-name": "Poonchavist",
                                "preferred-name": {
                                    "ce:given-name": "Poonchavist",
                                    "ce:initials": "P.",
                                    "ce:surname": "Chantranuwat",
                                    "ce:indexed-name": "Chantranuwat P."
                                },
                                "@seq": "7",
                                "@author-instance-id": "2015001130-93742aa91adecda7bdf590b8ef8c5504",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Chantranuwat",
                                "@auid": "36573266400",
                                "ce:indexed-name": "Chantranuwat P."
                            },
                            {
                                "ce:given-name": "Shanop",
                                "preferred-name": {
                                    "ce:given-name": "Shanop",
                                    "ce:initials": "S.",
                                    "ce:surname": "Shuangshoti",
                                    "ce:indexed-name": "Shuangshoti S."
                                },
                                "@seq": "8",
                                "@author-instance-id": "2015001130-6997bd27a234bd19691c013f993e6726",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Shuangshoti",
                                "@auid": "55063064300",
                                "ce:indexed-name": "Shuangshoti S."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10330",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Mathematics and Computer Science & Omics Science and Bioinformatics Center"},
                                {"$": "Faculty of Science"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "127689427"
                            },
                            "@affiliation-instance-id": "2015001130-105fcd4210daa1f1034e60bc152c58f1",
                            "ce:source-text": "Department of Mathematics and Computer Science & Omics Science and Bioinformatics Center, Faculty of Science, Chulalongkorn University, Bangkok, 10330, Thailand",
                            "@dptid": "127689427"
                        },
                        "author": [{
                            "ce:given-name": "Chatchawit",
                            "preferred-name": {
                                "ce:given-name": "Chatchawit",
                                "ce:initials": "C.",
                                "ce:surname": "Aporntewan",
                                "ce:indexed-name": "Aporntewan C."
                            },
                            "@seq": "9",
                            "@author-instance-id": "2015001130-8c8c3a8cca7f11161e42c4417da53ba3",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Aporntewan",
                            "@auid": "9335314400",
                            "ce:indexed-name": "Aporntewan C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Radiology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University and The King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60022183",
                                    "@dptid": "104136224"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2015001130-6d1e20eccffa8823515026448544f94a",
                            "ce:source-text": "Department of Radiology, Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, Thailand",
                            "@dptid": "104136224"
                        },
                        "author": [{
                            "ce:given-name": "Wariya",
                            "preferred-name": {
                                "ce:given-name": "Wariya",
                                "ce:initials": "W.",
                                "ce:surname": "Chintanapakdee",
                                "ce:indexed-name": "Chintanapakdee W."
                            },
                            "@seq": "10",
                            "@author-instance-id": "2015001130-d2e143bb6a3d0cfcc224c68184d76776",
                            "ce:initials": "W.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chintanapakdee",
                            "@auid": "57220047008",
                            "ce:indexed-name": "Chintanapakdee W."
                        }]
                    }
                ],
                "citation-title": "Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer",
                "abstracts": "© 2022, The Author(s).Despite the development of predictive biomarkers to shape treatment paradigms and outcomes, de novo EGFR TKI resistance advanced non-small cell lung cancer (NSCLC) remains an issue of concern. We explored clinical factors in 332 advanced NSCLC who received EGFR TKI and molecular characteristics through 65 whole exome sequencing of various EGFR TKI responses including; de novo (progression within 3 months), intermediate response (IRs) and long-term response (LTRs) (durability > 2 years). Uncommon EGFR mutation subtypes were significantly variable enriched in de novo resistance. The remaining sensitizing EGFR mutation subtypes (exon 19 del and L858R) accounted for 75% of de novo resistance. Genomic landscape analysis was conducted, focusing in 10 frequent oncogenic signaling pathways with functional contributions; cell cycle, Hippo, Myc, Notch, Nrf2, PI-3-Kinase/Akt, RTK-RAS, TGF-β, p53 and β-catenin/Wnt signaling. Cell cycle pathway was the only significant alteration pathway among groups with the FDR p-value of 6 × 10\u20134. We found only significant q-values of < 0.05 in 7 gene alterations; CDK6, CCNE1, CDK4, CCND3, MET, FGFR4 and HRAS which enrich in de novo resistance [range 36\u201373%] compared to IRs/LTRs [range 4\u201322%]. Amplification of CDK4/6 was significant in de novo resistance, contrary to IRs and LTRs (91%, 27.9% and 0%, respectively). The presence of co-occurrence CDK4/6 amplification correlated with poor disease outcome with HR of progression-free survival of 3.63 [95% CI 1.80\u20137.31, p-value < 0.001]. The presence of CDK4/6 amplification in pretreatment specimen serves as a predictive biomarker for de novo resistance in sensitizing EGFR mutation.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "postal-code": "10330",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Division of Medical Oncology"},
                            {"$": "Department of Medicine"},
                            {"$": "Faculty of Medicine"},
                            {"$": "Chulalongkorn University and The King Chulalongkorn Memorial Hospital"}
                        ],
                        "ce:source-text": "Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Chanida",
                        "ce:initials": "C.",
                        "ce:surname": "Vinayanuwattikun",
                        "ce:indexed-name": "Vinayanuwattikun C."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "www.nature.com/srep/index.html",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Scientific Reports",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {"voliss": {
                        "@volume": "12",
                        "@issue": "1"
                    }},
                    "@type": "j",
                    "sourcetitle": "Scientific Reports",
                    "publicationdate": {
                        "month": "12",
                        "year": "2022",
                        "date-text": "December 2022",
                        "day": "01"
                    },
                    "sourcetitle-abbrev": "Sci. Rep.",
                    "@country": "gbr",
                    "issn": {
                        "$": "20452322",
                        "@type": "electronic"
                    },
                    "publicationyear": {"@first": "2022"},
                    "publisher": {"publishername": "Nature Research"},
                    "article-number": "2167",
                    "@srcid": "21100200805"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "ASJC",
                            "classification": "1000"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MULT"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "147014-97-9",
                                    "chemical-name": "cyclin dependent kinase 4"
                                },
                                {
                                    "cas-registry-number": "79079-06-4",
                                    "chemical-name": "epidermal growth factor receptor"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Antineoplastic Agents"},
                                {"chemical-name": "Biomarkers"},
                                {"chemical-name": "CDK4 protein, human"},
                                {"chemical-name": "CDK6 protein, human"},
                                {"chemical-name": "Cyclin-Dependent Kinase 4"},
                                {"chemical-name": "Cyclin-Dependent Kinase 6"},
                                {"chemical-name": "EGFR protein, human"},
                                {"chemical-name": "ErbB Receptors"},
                                {"chemical-name": "Protein Kinase Inhibitors"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This research was supported by the Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University (Grant number RA60/121) to CV, Chulalongkorn Academic Advancement into Its 2nd Century (CUAASC) Project to VS and Health Systems Research Institute (Thailand) (Grant number 64-106) to CV. Biospecimen collection was supported by Biobank, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. The authors would like to thank Dr. Harit Suwanrusme for critical review of the manuscript.",
                        "@xml:lang": "eng"
                    },
                    "grant": {
                        "grant-id": "64/106",
                        "grant-acronym": "HSRI",
                        "grant-agency": {
                            "@iso-code": "tha",
                            "$": "Health Systems Research Institute"
                        },
                        "grant-agency-id": "501100010724"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "SNSOC"},
                    {"$": "Scopusbase"},
                    {"$": "MEDL"}
                ],
                "history": {"date-created": {
                    "@day": "21",
                    "@year": "2022",
                    "@timestamp": "BST 12:56:25",
                    "@month": "02"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2015001130",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "938615252",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "2022075128",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20220492762",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20220630754",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2022020476",
                            "@idtype": "SNSOC"
                        },
                        {
                            "$": "20219017615366",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85124312940",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85124312940",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "637217552",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "35140316",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "298817299",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1038/s41598-022-06239-y"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "54",
                "reference": [
                    {
                        "ref-fulltext": "Shi, Y. et al. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER). J. Thorac. Oncol. 9, 154\u2013162. 10.1097/JTO.0000000000000033 (2014). DOI: 10.1097/JTO.0000000000000033",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/JTO.0000000000000033",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84893353535",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "154",
                                    "@last": "162"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Shi",
                                    "ce:indexed-name": "Shi Y."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Thorac. Oncol."
                        },
                        "ce:source-text": "Shi, Y. et al. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER). J. Thorac. Oncol. 9, 154\u2013162. 10.1097/JTO.0000000000000033 (2014). DOI: 10.1097/JTO.0000000000000033"
                    },
                    {
                        "ref-fulltext": "Zhang, Y. L. et al. The prevalence of EGFR mutation in patients with non-small cell lung cancer: A systematic review and meta-analysis. Oncotarget 7, 78985\u201378993. 10.18632/oncotarget.12587 (2016). DOI: 10.18632/oncotarget.12587",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "The prevalence of EGFR mutation in patients with non-small cell lung cancer: A systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.18632/oncotarget.12587",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84999622577",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "78985",
                                    "@last": "78993"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Y.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang Y.L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncotarget"
                        },
                        "ce:source-text": "Zhang, Y. L. et al. The prevalence of EGFR mutation in patients with non-small cell lung cancer: A systematic review and meta-analysis. Oncotarget 7, 78985\u201378993. 10.18632/oncotarget.12587 (2016). DOI: 10.18632/oncotarget.12587"
                    },
                    {
                        "ref-fulltext": "Sriuranpong, V. et al. High frequency of mutation of epidermal growth factor receptor in lung adenocarcinoma in Thailand. Cancer Lett. 239, 292\u2013297. 10.1016/j.canlet.2005.08.029 (2006). DOI: 10.1016/j.canlet.2005.08.029",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "High frequency of mutation of epidermal growth factor receptor in lung adenocarcinoma in Thailand"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.canlet.2005.08.029",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33745699228",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "239"},
                                "pagerange": {
                                    "@first": "292",
                                    "@last": "297"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "V.",
                                    "@_fa": "true",
                                    "ce:surname": "Sriuranpong",
                                    "ce:indexed-name": "Sriuranpong V."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Lett."
                        },
                        "ce:source-text": "Sriuranpong, V. et al. High frequency of mutation of epidermal growth factor receptor in lung adenocarcinoma in Thailand. Cancer Lett. 239, 292\u2013297. 10.1016/j.canlet.2005.08.029 (2006). DOI: 10.1016/j.canlet.2005.08.029"
                    },
                    {
                        "ref-fulltext": "Mok, T. S. et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N. Engl. J. Med. 361, 947\u2013957. 10.1056/NEJMoa0810699 (2009). DOI: 10.1056/NEJMoa0810699",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa0810699",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "69949162760",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "361"},
                                "pagerange": {
                                    "@first": "947",
                                    "@last": "957"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Mok",
                                    "ce:indexed-name": "Mok T.S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N. Engl. J. Med."
                        },
                        "ce:source-text": "Mok, T. S. et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N. Engl. J. Med. 361, 947\u2013957. 10.1056/NEJMoa0810699 (2009). DOI: 10.1056/NEJMoa0810699"
                    },
                    {
                        "ref-fulltext": "Mitsudomi, T. et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): An open label, randomised phase 3 trial. Lancet Oncol. 11, 121\u2013128. 10.1016/S1470-2045(09)70364-X (2010). DOI: 10.1016/S1470-2045(09)70364-X",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): An open label, randomised phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S1470-2045(09)70364-X",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "75249087060",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "121",
                                    "@last": "128"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Mitsudomi",
                                    "ce:indexed-name": "Mitsudomi T."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol."
                        },
                        "ce:source-text": "Mitsudomi, T. et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): An open label, randomised phase 3 trial. Lancet Oncol. 11, 121\u2013128. 10.1016/S1470-2045(09)70364-X (2010). DOI: 10.1016/S1470-2045(09)70364-X"
                    },
                    {
                        "ref-fulltext": "Maemondo, M. et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N. Engl. J. Med. 362, 2380\u20132388. 10.1056/NEJMoa0909530 (2010). DOI: 10.1056/NEJMoa0909530",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa0909530",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77953930730",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "362"},
                                "pagerange": {
                                    "@first": "2380",
                                    "@last": "2388"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Maemondo",
                                    "ce:indexed-name": "Maemondo M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N. Engl. J. Med."
                        },
                        "ce:source-text": "Maemondo, M. et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N. Engl. J. Med. 362, 2380\u20132388. 10.1056/NEJMoa0909530 (2010). DOI: 10.1056/NEJMoa0909530"
                    },
                    {
                        "ref-fulltext": "Zhou, C. et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): A multicentre, open-label, randomised, phase 3 study. Lancet Oncol. 12, 735\u2013742. 10.1016/S1470-2045(11)70184-X (2011). DOI: 10.1016/S1470-2045(11)70184-X",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): A multicentre, open-label, randomised, phase 3 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S1470-2045(11)70184-X",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79960889662",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "735",
                                    "@last": "742"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhou",
                                    "ce:indexed-name": "Zhou C."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol."
                        },
                        "ce:source-text": "Zhou, C. et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): A multicentre, open-label, randomised, phase 3 study. Lancet Oncol. 12, 735\u2013742. 10.1016/S1470-2045(11)70184-X (2011). DOI: 10.1016/S1470-2045(11)70184-X"
                    },
                    {
                        "ref-fulltext": "Rosell, R. et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial. Lancet Oncol. 13, 239\u2013246. 10.1016/S1470-2045(11)70393-X (2012). DOI: 10.1016/S1470-2045(11)70393-X",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S1470-2045(11)70393-X",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84857502654",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "239",
                                    "@last": "246"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Rosell",
                                    "ce:indexed-name": "Rosell R."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol."
                        },
                        "ce:source-text": "Rosell, R. et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial. Lancet Oncol. 13, 239\u2013246. 10.1016/S1470-2045(11)70393-X (2012). DOI: 10.1016/S1470-2045(11)70393-X"
                    },
                    {
                        "ref-fulltext": "Wu, Y. L. et al. First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: Analyses from the phase III, randomized, open-label ENSURE study. Ann. Oncol. 26, 1883\u20131889. 10.1093/annonc/mdv270 (2015). DOI: 10.1093/annonc/mdv270",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: Analyses from the phase III, randomized, open-label ENSURE study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdv270",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84941629860",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "1883",
                                    "@last": "1889"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Y.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Wu",
                                    "ce:indexed-name": "Wu Y.L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann. Oncol."
                        },
                        "ce:source-text": "Wu, Y. L. et al. First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: Analyses from the phase III, randomized, open-label ENSURE study. Ann. Oncol. 26, 1883\u20131889. 10.1093/annonc/mdv270 (2015). DOI: 10.1093/annonc/mdv270"
                    },
                    {
                        "ref-fulltext": "Sequist, L. V. et al. Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. J. Clin. Oncol. 31, 3327\u20133334. 10.1200/JCO.2012.44.2806 (2013). DOI: 10.1200/JCO.2012.44.2806",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1200/JCO.2012.44.2806",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84884736973",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "3327",
                                    "@last": "3334"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "L.V.",
                                    "@_fa": "true",
                                    "ce:surname": "Sequist",
                                    "ce:indexed-name": "Sequist L.V."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Oncol."
                        },
                        "ce:source-text": "Sequist, L. V. et al. Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. J. Clin. Oncol. 31, 3327\u20133334. 10.1200/JCO.2012.44.2806 (2013). DOI: 10.1200/JCO.2012.44.2806"
                    },
                    {
                        "ref-fulltext": "Wu, Y. L. et al. Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): An open-label, randomised phase 3 trial. Lancet Oncol. 15, 213\u2013222. 10.1016/S1470-2045(13)70604-1 (2014). DOI: 10.1016/S1470-2045(13)70604-1",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): An open-label, randomised phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S1470-2045(13)70604-1",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84892997539",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "213",
                                    "@last": "222"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Y.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Wu",
                                    "ce:indexed-name": "Wu Y.L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol."
                        },
                        "ce:source-text": "Wu, Y. L. et al. Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): An open-label, randomised phase 3 trial. Lancet Oncol. 15, 213\u2013222. 10.1016/S1470-2045(13)70604-1 (2014). DOI: 10.1016/S1470-2045(13)70604-1"
                    },
                    {
                        "ref-fulltext": "Riely, G. J. et al. Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib. Clin. Cancer Res. 12, 839\u2013844. 10.1158/1078-0432.CCR-05-1846 (2006). DOI: 10.1158/1078-0432.CCR-05-1846",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/1078-0432.CCR-05-1846",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "32944481596",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "839",
                                    "@last": "844"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "G.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Riely",
                                    "ce:indexed-name": "Riely G.J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Cancer Res."
                        },
                        "ce:source-text": "Riely, G. J. et al. Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib. Clin. Cancer Res. 12, 839\u2013844. 10.1158/1078-0432.CCR-05-1846 (2006). DOI: 10.1158/1078-0432.CCR-05-1846"
                    },
                    {
                        "ref-fulltext": "Jackman, D. M. et al. Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib. Clin. Cancer Res. 12, 3908\u20133914. 10.1158/1078-0432.CCR-06-0462 (2006). DOI: 10.1158/1078-0432.CCR-06-0462",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/1078-0432.CCR-06-0462",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33746034167",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "3908",
                                    "@last": "3914"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "D.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Jackman",
                                    "ce:indexed-name": "Jackman D.M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Cancer Res."
                        },
                        "ce:source-text": "Jackman, D. M. et al. Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib. Clin. Cancer Res. 12, 3908\u20133914. 10.1158/1078-0432.CCR-06-0462 (2006). DOI: 10.1158/1078-0432.CCR-06-0462"
                    },
                    {
                        "ref-fulltext": "Wang, J., Wang, B., Chu, H. & Yao, Y. Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations. Onco Targets Ther. 9, 3711\u20133726. 10.2147/OTT.S106399 (2016). DOI: 10.2147/OTT.S106399",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2147/OTT.S106399",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84976285844",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "3711",
                                    "@last": "3726"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang B."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Chu",
                                    "ce:indexed-name": "Chu H."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Yao",
                                    "ce:indexed-name": "Yao Y."
                                }
                            ]},
                            "ref-sourcetitle": "Onco Targets Ther."
                        },
                        "ce:source-text": "Wang, J., Wang, B., Chu, H. & Yao, Y. Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations. Onco Targets Ther. 9, 3711\u20133726. 10.2147/OTT.S106399 (2016). DOI: 10.2147/OTT.S106399"
                    },
                    {
                        "ref-fulltext": "Stewart, E. L., Tan, S. Z., Liu, G. & Tsao, M. S. Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review. Transl. Lung Cancer Res. 4, 67\u201381. 10.3978/j.issn.2218-6751.2014.11.06 (2015). DOI: 10.3978/j.issn.2218-6751.2014.11.06",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3978/j.issn.2218-6751.2014.11.06",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84948139289",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "67",
                                    "@last": "81"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Stewart",
                                    "ce:indexed-name": "Stewart E.L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.Z.",
                                    "@_fa": "true",
                                    "ce:surname": "Tan",
                                    "ce:indexed-name": "Tan S.Z."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Liu",
                                    "ce:indexed-name": "Liu G."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Tsao",
                                    "ce:indexed-name": "Tsao M.S."
                                }
                            ]},
                            "ref-sourcetitle": "Transl. Lung Cancer Res."
                        },
                        "ce:source-text": "Stewart, E. L., Tan, S. Z., Liu, G. & Tsao, M. S. Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review. Transl. Lung Cancer Res. 4, 67\u201381. 10.3978/j.issn.2218-6751.2014.11.06 (2015). DOI: 10.3978/j.issn.2218-6751.2014.11.06"
                    },
                    {
                        "ref-fulltext": "Lee, J. K. et al. Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study. Ann. Oncol. 24, 2080\u20132087. 10.1093/annonc/mdt127 (2013). DOI: 10.1093/annonc/mdt127",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdt127",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84881253216",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "2080",
                                    "@last": "2087"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee J.K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann. Oncol."
                        },
                        "ce:source-text": "Lee, J. K. et al. Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study. Ann. Oncol. 24, 2080\u20132087. 10.1093/annonc/mdt127 (2013). DOI: 10.1093/annonc/mdt127"
                    },
                    {
                        "ref-fulltext": "Jackman, D. et al. Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. J. Clin. Oncol. 28, 357\u2013360. 10.1200/JCO.2009.24.7049 (2010). DOI: 10.1200/JCO.2009.24.7049",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1200/JCO.2009.24.7049",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "74949110711",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "357",
                                    "@last": "360"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Jackman",
                                    "ce:indexed-name": "Jackman D."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Oncol."
                        },
                        "ce:source-text": "Jackman, D. et al. Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. J. Clin. Oncol. 28, 357\u2013360. 10.1200/JCO.2009.24.7049 (2010). DOI: 10.1200/JCO.2009.24.7049"
                    },
                    {
                        "ref-fulltext": "Gautschi, O. et al. Mutation profiling of lung cancers with long-term response to gefitinib therapy. Oncol. Res. Treat. 38, 560\u2013569. 10.1159/000441367 (2015). DOI: 10.1159/000441367",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Mutation profiling of lung cancers with long-term response to gefitinib therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1159/000441367",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84948703322",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "38"},
                                "pagerange": {
                                    "@first": "560",
                                    "@last": "569"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "O.",
                                    "@_fa": "true",
                                    "ce:surname": "Gautschi",
                                    "ce:indexed-name": "Gautschi O."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncol. Res. Treat."
                        },
                        "ce:source-text": "Gautschi, O. et al. Mutation profiling of lung cancers with long-term response to gefitinib therapy. Oncol. Res. Treat. 38, 560\u2013569. 10.1159/000441367 (2015). DOI: 10.1159/000441367"
                    },
                    {
                        "ref-fulltext": "Chen, J. et al. Genomic landscape of lung adenocarcinoma in East Asians. Nat. Genet. 52, 177\u2013186. 10.1038/s41588-019-0569-6 (2020). DOI: 10.1038/s41588-019-0569-6",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Genomic landscape of lung adenocarcinoma in East Asians"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/s41588-019-0569-6",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85079162414",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "52"},
                                "pagerange": {
                                    "@first": "177",
                                    "@last": "186"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat. Genet."
                        },
                        "ce:source-text": "Chen, J. et al. Genomic landscape of lung adenocarcinoma in East Asians. Nat. Genet. 52, 177\u2013186. 10.1038/s41588-019-0569-6 (2020). DOI: 10.1038/s41588-019-0569-6"
                    },
                    {
                        "ref-fulltext": "Oh, S. et al. Reliable analysis of clinical tumor-only whole-exome sequencing data. JCO Clin. Cancer Inform. 4, 321\u2013335. 10.1200/CCI.19.00130 (2020). DOI: 10.1200/CCI.19.00130",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Reliable analysis of clinical tumor-only whole-exome sequencing data"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1200/CCI.19.00130",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85083364611",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "321",
                                    "@last": "335"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Oh",
                                    "ce:indexed-name": "Oh S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JCO Clin. Cancer Inform."
                        },
                        "ce:source-text": "Oh, S. et al. Reliable analysis of clinical tumor-only whole-exome sequencing data. JCO Clin. Cancer Inform. 4, 321\u2013335. 10.1200/CCI.19.00130 (2020). DOI: 10.1200/CCI.19.00130"
                    },
                    {
                        "ref-fulltext": "Sanchez-Vega, F. et al. Oncogenic signaling pathways in the cancer genome atlas. Cell 173, 321\u2013337. 10.1016/j.cell.2018.03.035 (2018). DOI: 10.1016/j.cell.2018.03.035",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Oncogenic signaling pathways in the cancer genome atlas"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.cell.2018.03.035",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85044966521",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "173"},
                                "pagerange": {
                                    "@first": "321",
                                    "@last": "337"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Sanchez-Vega",
                                    "ce:indexed-name": "Sanchez-Vega F."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cell"
                        },
                        "ce:source-text": "Sanchez-Vega, F. et al. Oncogenic signaling pathways in the cancer genome atlas. Cell 173, 321\u2013337. 10.1016/j.cell.2018.03.035 (2018). DOI: 10.1016/j.cell.2018.03.035"
                    },
                    {
                        "ref-fulltext": "Gini, B., Thomas, N. & Blakely, C. M. Impact of concurrent genomic alterations in epidermal growth factor receptor (EGFR)-mutated lung cancer. J. Thorac. Dis. 12, 2883\u20132895. 10.21037/jtd.2020.03.78 (2020). DOI: 10.21037/jtd.2020.03.78",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Impact of concurrent genomic alterations in epidermal growth factor receptor (EGFR)-mutated lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.21037/jtd.2020.03.78",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85086031880",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "2883",
                                    "@last": "2895"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Gini",
                                    "ce:indexed-name": "Gini B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Thomas",
                                    "ce:indexed-name": "Thomas N."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Blakely",
                                    "ce:indexed-name": "Blakely C.M."
                                }
                            ]},
                            "ref-sourcetitle": "J. Thorac. Dis."
                        },
                        "ce:source-text": "Gini, B., Thomas, N. & Blakely, C. M. Impact of concurrent genomic alterations in epidermal growth factor receptor (EGFR)-mutated lung cancer. J. Thorac. Dis. 12, 2883\u20132895. 10.21037/jtd.2020.03.78 (2020). DOI: 10.21037/jtd.2020.03.78"
                    },
                    {
                        "ref-fulltext": "Cao, J. et al. An accurate and comprehensive clinical sequencing assay for cancer targeted and immunotherapies. Oncologist 24, e1294\u2013e1302. 10.1634/theoncologist.2019-0236 (2019). DOI: 10.1634/theoncologist.2019-0236",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "An accurate and comprehensive clinical sequencing assay for cancer targeted and immunotherapies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1634/theoncologist.2019-0236",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85071151079",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "e1294",
                                    "@last": "e1302"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Cao",
                                    "ce:indexed-name": "Cao J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Cao, J. et al. An accurate and comprehensive clinical sequencing assay for cancer targeted and immunotherapies. Oncologist 24, e1294\u2013e1302. 10.1634/theoncologist.2019-0236 (2019). DOI: 10.1634/theoncologist.2019-0236"
                    },
                    {
                        "ref-fulltext": "Park, S. et al. Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer. J. Thorac. Oncol. 4, 809\u2013815. 10.1097/JTO.0b013e3181a94af4 (2009). DOI: 10.1097/JTO.0b013e3181a94af4",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/JTO.0b013e3181a94af4",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "68549111225",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "809",
                                    "@last": "815"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Park",
                                    "ce:indexed-name": "Park S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Thorac. Oncol."
                        },
                        "ce:source-text": "Park, S. et al. Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer. J. Thorac. Oncol. 4, 809\u2013815. 10.1097/JTO.0b013e3181a94af4 (2009). DOI: 10.1097/JTO.0b013e3181a94af4"
                    },
                    {
                        "ref-fulltext": "Monaco, S. E. et al. A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases. Hum. Pathol. 41, 94\u2013102. 10.1016/j.humpath.2009.06.019 (2010). DOI: 10.1016/j.humpath.2009.06.019",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.humpath.2009.06.019",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "71049185583",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "94",
                                    "@last": "102"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Monaco",
                                    "ce:indexed-name": "Monaco S.E."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hum. Pathol."
                        },
                        "ce:source-text": "Monaco, S. E. et al. A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases. Hum. Pathol. 41, 94\u2013102. 10.1016/j.humpath.2009.06.019 (2010). DOI: 10.1016/j.humpath.2009.06.019"
                    },
                    {
                        "ref-fulltext": "Hasegawa, Y. et al. The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: A meta-analysis of prospective randomized trials. Oncologist 20, 307\u2013315. 10.1634/theoncologist.2014-0285 (2015). DOI: 10.1634/theoncologist.2014-0285",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: A meta-analysis of prospective randomized trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1634/theoncologist.2014-0285",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR26",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84925393659",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "307",
                                    "@last": "315"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Hasegawa",
                                    "ce:indexed-name": "Hasegawa Y."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Hasegawa, Y. et al. The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: A meta-analysis of prospective randomized trials. Oncologist 20, 307\u2013315. 10.1634/theoncologist.2014-0285 (2015). DOI: 10.1634/theoncologist.2014-0285"
                    },
                    {
                        "ref-fulltext": "Han, J. Y. et al. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma. Lung Cancer 85, 161\u2013167. 10.1016/j.lungcan.2014.04.009 (2014). DOI: 10.1016/j.lungcan.2014.04.009",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.lungcan.2014.04.009",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR27",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84904122641",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "85"},
                                "pagerange": {
                                    "@first": "161",
                                    "@last": "167"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Han",
                                    "ce:indexed-name": "Han J.Y."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lung Cancer"
                        },
                        "ce:source-text": "Han, J. Y. et al. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma. Lung Cancer 85, 161\u2013167. 10.1016/j.lungcan.2014.04.009 (2014). DOI: 10.1016/j.lungcan.2014.04.009"
                    },
                    {
                        "ref-fulltext": "Lim, S. M. et al. Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium). Oncotarget 7, 36311\u201336320. 10.18632/oncotarget.8904 (2016). DOI: 10.18632/oncotarget.8904",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.18632/oncotarget.8904",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR28",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84978045120",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "36311",
                                    "@last": "36320"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Lim",
                                    "ce:indexed-name": "Lim S.M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncotarget"
                        },
                        "ce:source-text": "Lim, S. M. et al. Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium). Oncotarget 7, 36311\u201336320. 10.18632/oncotarget.8904 (2016). DOI: 10.18632/oncotarget.8904"
                    },
                    {
                        "ref-fulltext": "Sos, M. L. et al. PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR. Cancer Res. 69, 3256\u20133261. 10.1158/0008-5472.CAN-08-4055 (2009). DOI: 10.1158/0008-5472.CAN-08-4055",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/0008-5472.CAN-08-4055",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR29",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "65949086609",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "69"},
                                "pagerange": {
                                    "@first": "3256",
                                    "@last": "3261"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Sos",
                                    "ce:indexed-name": "Sos M.L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Res."
                        },
                        "ce:source-text": "Sos, M. L. et al. PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR. Cancer Res. 69, 3256\u20133261. 10.1158/0008-5472.CAN-08-4055 (2009). DOI: 10.1158/0008-5472.CAN-08-4055"
                    },
                    {
                        "ref-fulltext": "Engelman, J. A. et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316, 1039\u20131043. 10.1126/science.1141478 (2007). DOI: 10.1126/science.1141478",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1126/science.1141478",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR30",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34249075147",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "316"},
                                "pagerange": {
                                    "@first": "1039",
                                    "@last": "1043"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Engelman",
                                    "ce:indexed-name": "Engelman J.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Science"
                        },
                        "ce:source-text": "Engelman, J. A. et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316, 1039\u20131043. 10.1126/science.1141478 (2007). DOI: 10.1126/science.1141478"
                    },
                    {
                        "ref-fulltext": "Cappuzzo, F. et al. MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients. Ann. Oncol. 20, 298\u2013304. 10.1093/annonc/mdn635 (2009). DOI: 10.1093/annonc/mdn635",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdn635",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR31",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "60549110433",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "298",
                                    "@last": "304"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Cappuzzo",
                                    "ce:indexed-name": "Cappuzzo F."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann. Oncol."
                        },
                        "ce:source-text": "Cappuzzo, F. et al. MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients. Ann. Oncol. 20, 298\u2013304. 10.1093/annonc/mdn635 (2009). DOI: 10.1093/annonc/mdn635"
                    },
                    {
                        "ref-fulltext": "Benedettini, E. et al. Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis. Am. J. Pathol. 177, 415\u2013423. 10.2353/ajpath.2010.090863 (2010). DOI: 10.2353/ajpath.2010.090863",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2353/ajpath.2010.090863",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR32",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77954586493",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "177"},
                                "pagerange": {
                                    "@first": "415",
                                    "@last": "423"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Benedettini",
                                    "ce:indexed-name": "Benedettini E."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am. J. Pathol."
                        },
                        "ce:source-text": "Benedettini, E. et al. Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis. Am. J. Pathol. 177, 415\u2013423. 10.2353/ajpath.2010.090863 (2010). DOI: 10.2353/ajpath.2010.090863"
                    },
                    {
                        "ref-fulltext": "Qin, K., Hou, H., Liang, Y. & Zhang, X. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis. BMC Cancer 20, 328. 10.1186/s12885-020-06805-5 (2020). DOI: 10.1186/s12885-020-06805-5",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s12885-020-06805-5",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR33",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85083631772",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {"@first": "328"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Qin",
                                    "ce:indexed-name": "Qin K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Hou",
                                    "ce:indexed-name": "Hou H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Liang",
                                    "ce:indexed-name": "Liang Y."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang X."
                                }
                            ]},
                            "ref-sourcetitle": "BMC Cancer"
                        },
                        "ce:source-text": "Qin, K., Hou, H., Liang, Y. & Zhang, X. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis. BMC Cancer 20, 328. 10.1186/s12885-020-06805-5 (2020). DOI: 10.1186/s12885-020-06805-5"
                    },
                    {
                        "ref-fulltext": "Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546\u20131558. 10.1126/science.1235122 (2013). DOI: 10.1126/science.1235122",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Cancer genome landscapes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1126/science.1235122",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR34",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84875490185",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "339"},
                                "pagerange": {
                                    "@first": "1546",
                                    "@last": "1558"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Vogelstein",
                                    "ce:indexed-name": "Vogelstein B."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Science"
                        },
                        "ce:source-text": "Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546\u20131558. 10.1126/science.1235122 (2013). DOI: 10.1126/science.1235122"
                    },
                    {
                        "ref-fulltext": "Vogelstein, B. & Kinzler, K. W. Cancer genes and the pathways they control. Nat. Med. 10, 789\u2013799. 10.1038/nm1087 (2004). DOI: 10.1038/nm1087",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Cancer genes and the pathways they control"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/nm1087",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR35",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "4043181214",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "789",
                                    "@last": "799"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Vogelstein",
                                    "ce:indexed-name": "Vogelstein B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Kinzler",
                                    "ce:indexed-name": "Kinzler K.W."
                                }
                            ]},
                            "ref-sourcetitle": "Nat. Med."
                        },
                        "ce:source-text": "Vogelstein, B. & Kinzler, K. W. Cancer genes and the pathways they control. Nat. Med. 10, 789\u2013799. 10.1038/nm1087 (2004). DOI: 10.1038/nm1087"
                    },
                    {
                        "ref-fulltext": "Lee, T. G. et al. Altered expression of cellular proliferation, apoptosis and the cell cycle-related genes in lung cancer cells with acquired resistance to EGFR tyrosine kinase inhibitors. Oncol. Lett. 14, 2191\u20132197. 10.3892/ol.2017.6428 (2017). DOI: 10.3892/ol.2017.6428",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Altered expression of cellular proliferation, apoptosis and the cell cycle-related genes in lung cancer cells with acquired resistance to EGFR tyrosine kinase inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3892/ol.2017.6428",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR36",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85021759511",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "2191",
                                    "@last": "2197"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee T.G."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncol. Lett."
                        },
                        "ce:source-text": "Lee, T. G. et al. Altered expression of cellular proliferation, apoptosis and the cell cycle-related genes in lung cancer cells with acquired resistance to EGFR tyrosine kinase inhibitors. Oncol. Lett. 14, 2191\u20132197. 10.3892/ol.2017.6428 (2017). DOI: 10.3892/ol.2017.6428"
                    },
                    {
                        "ref-fulltext": "Blakely, C. M. et al. Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers. Nat. Genet. 49, 1693\u20131704. 10.1038/ng.3990 (2017). DOI: 10.1038/ng.3990",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/ng.3990",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR37",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85035788250",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "49"},
                                "pagerange": {
                                    "@first": "1693",
                                    "@last": "1704"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Blakely",
                                    "ce:indexed-name": "Blakely C.M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat. Genet."
                        },
                        "ce:source-text": "Blakely, C. M. et al. Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers. Nat. Genet. 49, 1693\u20131704. 10.1038/ng.3990 (2017). DOI: 10.1038/ng.3990"
                    },
                    {
                        "ref-fulltext": "Wang, Q., Yang, S., Wang, K. & Sun, S. Y. MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer. J. Hematol. Oncol. 12, 63. 10.1186/s13045-019-0759-9 (2019). DOI: 10.1186/s13045-019-0759-9",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s13045-019-0759-9",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR38",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85068497250",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {"@first": "63"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Q.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang Q."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Yang",
                                    "ce:indexed-name": "Yang S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang K."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Sun",
                                    "ce:indexed-name": "Sun S.Y."
                                }
                            ]},
                            "ref-sourcetitle": "J. Hematol. Oncol."
                        },
                        "ce:source-text": "Wang, Q., Yang, S., Wang, K. & Sun, S. Y. MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer. J. Hematol. Oncol. 12, 63. 10.1186/s13045-019-0759-9 (2019). DOI: 10.1186/s13045-019-0759-9"
                    },
                    {
                        "ref-fulltext": "Ramalingam, S. S. et al. LBA50\u2014Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study. Ann. Oncol. 29, 740. 10.1093/annonc/mdy424.063 (2018). DOI: 10.1093/annonc/mdy424.063",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "LBA50\u2014Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdy424.063",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR39",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85061579876",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {"@first": "740"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Ramalingam",
                                    "ce:indexed-name": "Ramalingam S.S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann. Oncol."
                        },
                        "ce:source-text": "Ramalingam, S. S. et al. LBA50\u2014Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study. Ann. Oncol. 29, 740. 10.1093/annonc/mdy424.063 (2018). DOI: 10.1093/annonc/mdy424.063"
                    },
                    {
                        "ref-fulltext": "Shi, P. et al. Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment. Cancer Lett. 380, 494\u2013504. 10.1016/j.canlet.2016.07.021 (2016). DOI: 10.1016/j.canlet.2016.07.021",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.canlet.2016.07.021",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR40",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84979306616",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "380"},
                                "pagerange": {
                                    "@first": "494",
                                    "@last": "504"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Shi",
                                    "ce:indexed-name": "Shi P."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Lett."
                        },
                        "ce:source-text": "Shi, P. et al. Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment. Cancer Lett. 380, 494\u2013504. 10.1016/j.canlet.2016.07.021 (2016). DOI: 10.1016/j.canlet.2016.07.021"
                    },
                    {
                        "ref-fulltext": "Ortiz-Cuaran, S. et al. Heterogeneous mechanisms of primary and acquired resistance to third-generation EGFR inhibitors. Clin. Cancer Res. 22, 4837\u20134847. 10.1158/1078-0432.CCR-15-1915 (2016). DOI: 10.1158/1078-0432.CCR-15-1915",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Heterogeneous mechanisms of primary and acquired resistance to third-generation EGFR inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/1078-0432.CCR-15-1915",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR41",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84991241383",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "4837",
                                    "@last": "4847"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Ortiz-Cuaran",
                                    "ce:indexed-name": "Ortiz-Cuaran S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Cancer Res."
                        },
                        "ce:source-text": "Ortiz-Cuaran, S. et al. Heterogeneous mechanisms of primary and acquired resistance to third-generation EGFR inhibitors. Clin. Cancer Res. 22, 4837\u20134847. 10.1158/1078-0432.CCR-15-1915 (2016). DOI: 10.1158/1078-0432.CCR-15-1915"
                    },
                    {
                        "ref-fulltext": "Leonetti, A. et al. Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer. Br. J. Cancer 121, 725\u2013737. 10.1038/s41416-019-0573-8 (2019). DOI: 10.1038/s41416-019-0573-8",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/s41416-019-0573-8",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR42",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85074293851",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "121"},
                                "pagerange": {
                                    "@first": "725",
                                    "@last": "737"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Leonetti",
                                    "ce:indexed-name": "Leonetti A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br. J. Cancer"
                        },
                        "ce:source-text": "Leonetti, A. et al. Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer. Br. J. Cancer 121, 725\u2013737. 10.1038/s41416-019-0573-8 (2019). DOI: 10.1038/s41416-019-0573-8"
                    },
                    {
                        "ref-fulltext": "Kim, Y. et al. Concurrent genetic alterations predict the progression to target therapy in EGFR-mutated advanced NSCLC. J. Thorac. Oncol. 14, 193\u2013202. 10.1016/j.jtho.2018.10.150 (2019). DOI: 10.1016/j.jtho.2018.10.150",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Concurrent genetic alterations predict the progression to target therapy in EGFR-mutated advanced NSCLC"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jtho.2018.10.150",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR43",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85060347821",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "193",
                                    "@last": "202"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Kim",
                                    "ce:indexed-name": "Kim Y."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Thorac. Oncol."
                        },
                        "ce:source-text": "Kim, Y. et al. Concurrent genetic alterations predict the progression to target therapy in EGFR-mutated advanced NSCLC. J. Thorac. Oncol. 14, 193\u2013202. 10.1016/j.jtho.2018.10.150 (2019). DOI: 10.1016/j.jtho.2018.10.150"
                    },
                    {
                        "ref-fulltext": "Bhateja, P. et al. Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer. Cancer Med. 8, 1459\u20131466. 10.1002/cam4.2023 (2019). DOI: 10.1002/cam4.2023",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/cam4.2023",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR44",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85065073247",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "1459",
                                    "@last": "1466"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Bhateja",
                                    "ce:indexed-name": "Bhateja P."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Med."
                        },
                        "ce:source-text": "Bhateja, P. et al. Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer. Cancer Med. 8, 1459\u20131466. 10.1002/cam4.2023 (2019). DOI: 10.1002/cam4.2023"
                    },
                    {
                        "ref-fulltext": "Anders, L. et al. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell 20, 620\u2013634. 10.1016/j.ccr.2011.10.001 (2011). DOI: 10.1016/j.ccr.2011.10.001",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.ccr.2011.10.001",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR45",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "81255205373",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "620",
                                    "@last": "634"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Anders",
                                    "ce:indexed-name": "Anders L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Cell"
                        },
                        "ce:source-text": "Anders, L. et al. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell 20, 620\u2013634. 10.1016/j.ccr.2011.10.001 (2011). DOI: 10.1016/j.ccr.2011.10.001"
                    },
                    {
                        "ref-fulltext": "Wang, H. et al. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival. Nature 546, 426\u2013430. 10.1038/nature22797 (2017). DOI: 10.1038/nature22797",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/nature22797",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR46",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85020944294",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "546"},
                                "pagerange": {
                                    "@first": "426",
                                    "@last": "430"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang H."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Wang, H. et al. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival. Nature 546, 426\u2013430. 10.1038/nature22797 (2017). DOI: 10.1038/nature22797"
                    },
                    {
                        "ref-fulltext": "Lagarrigue, S. et al. CDK4 is an essential insulin effector in adipocytes. J. Clin. Invest. 126, 335\u2013348. 10.1172/JCI81480 (2016). DOI: 10.1172/JCI81480",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "CDK4 is an essential insulin effector in adipocytes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1172/JCI81480",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR47",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84956676264",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "126"},
                                "pagerange": {
                                    "@first": "335",
                                    "@last": "348"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Lagarrigue",
                                    "ce:indexed-name": "Lagarrigue S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Invest."
                        },
                        "ce:source-text": "Lagarrigue, S. et al. CDK4 is an essential insulin effector in adipocytes. J. Clin. Invest. 126, 335\u2013348. 10.1172/JCI81480 (2016). DOI: 10.1172/JCI81480"
                    },
                    {
                        "ref-fulltext": "Deng, J. et al. CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation. Cancer Discov. 8, 216\u2013233. 10.1158/2159-8290.CD-17-0915 (2018). DOI: 10.1158/2159-8290.CD-17-0915",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/2159-8290.CD-17-0915",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR48",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85041378182",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "216",
                                    "@last": "233"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Deng",
                                    "ce:indexed-name": "Deng J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Discov."
                        },
                        "ce:source-text": "Deng, J. et al. CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation. Cancer Discov. 8, 216\u2013233. 10.1158/2159-8290.CD-17-0915 (2018). DOI: 10.1158/2159-8290.CD-17-0915"
                    },
                    {
                        "ref-fulltext": "La Monica, S. et al. Efficacy of the CDK4/6 dual inhibitor abemaciclib in EGFR-mutated NSCLC cell lines with different resistance mechanisms to osimertinib. Cancers 10.3390/cancers13010006 (2020). DOI: 10.3390/cancers13010006",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Efficacy of the CDK4/6 dual inhibitor abemaciclib in EGFR-mutated NSCLC cell lines with different resistance mechanisms to osimertinib"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3390/cancers13010006",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR49",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85098646405",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "La Monica",
                                    "ce:indexed-name": "La Monica S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancers"
                        },
                        "ce:source-text": "La Monica, S. et al. Efficacy of the CDK4/6 dual inhibitor abemaciclib in EGFR-mutated NSCLC cell lines with different resistance mechanisms to osimertinib. Cancers 10.3390/cancers13010006 (2020). DOI: 10.3390/cancers13010006"
                    },
                    {
                        "ref-fulltext": "Piotrowska, Z. et al. Landscape of acquired resistance to osimertinib in EGFR-mutant NSCLC and clinical validation of combined EGFR and RET inhibition with osimertinib and BLU-667 for acquired RET fusion. Cancer Discov. 8, 1529\u20131539. 10.1158/2159-8290.CD-18-1022 (2018). DOI: 10.1158/2159-8290.CD-18-1022",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Landscape of acquired resistance to osimertinib in EGFR-mutant NSCLC and clinical validation of combined EGFR and RET inhibition with osimertinib and BLU-667 for acquired RET fusion"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/2159-8290.CD-18-1022",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR50",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85058024415",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "1529",
                                    "@last": "1539"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Z.",
                                    "@_fa": "true",
                                    "ce:surname": "Piotrowska",
                                    "ce:indexed-name": "Piotrowska Z."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Discov."
                        },
                        "ce:source-text": "Piotrowska, Z. et al. Landscape of acquired resistance to osimertinib in EGFR-mutant NSCLC and clinical validation of combined EGFR and RET inhibition with osimertinib and BLU-667 for acquired RET fusion. Cancer Discov. 8, 1529\u20131539. 10.1158/2159-8290.CD-18-1022 (2018). DOI: 10.1158/2159-8290.CD-18-1022"
                    },
                    {
                        "ref-fulltext": "Zeng, L., Yang, N. & Zhang, Y. GOPC-ROS1 rearrangement as an acquired resistance mechanism to osimertinib and responding to crizotinib combined treatments in lung adenocarcinoma. J. Thorac. Oncol. 13, e114\u2013e116. 10.1016/j.jtho.2018.02.005 (2018). DOI: 10.1016/j.jtho.2018.02.005",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "GOPC-ROS1 rearrangement as an acquired resistance mechanism to osimertinib and responding to crizotinib combined treatments in lung adenocarcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jtho.2018.02.005",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR51",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85048838968",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "e114",
                                    "@last": "e116"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Zeng",
                                    "ce:indexed-name": "Zeng L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Yang",
                                    "ce:indexed-name": "Yang N."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang Y."
                                }
                            ]},
                            "ref-sourcetitle": "J. Thorac. Oncol."
                        },
                        "ce:source-text": "Zeng, L., Yang, N. & Zhang, Y. GOPC-ROS1 rearrangement as an acquired resistance mechanism to osimertinib and responding to crizotinib combined treatments in lung adenocarcinoma. J. Thorac. Oncol. 13, e114\u2013e116. 10.1016/j.jtho.2018.02.005 (2018). DOI: 10.1016/j.jtho.2018.02.005"
                    },
                    {
                        "ref-fulltext": "Schrock, A. B. et al. Receptor tyrosine kinase fusions and BRAF kinase fusions are rare but actionable resistance mechanisms to EGFR tyrosine kinase inhibitors. J. Thorac. Oncol. 13, 1312\u20131323. 10.1016/j.jtho.2018.05.027 (2018). DOI: 10.1016/j.jtho.2018.05.027",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Receptor tyrosine kinase fusions and BRAF kinase fusions are rare but actionable resistance mechanisms to EGFR tyrosine kinase inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jtho.2018.05.027",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR52",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85050338583",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "1312",
                                    "@last": "1323"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Schrock",
                                    "ce:indexed-name": "Schrock A.B."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Thorac. Oncol."
                        },
                        "ce:source-text": "Schrock, A. B. et al. Receptor tyrosine kinase fusions and BRAF kinase fusions are rare but actionable resistance mechanisms to EGFR tyrosine kinase inhibitors. J. Thorac. Oncol. 13, 1312\u20131323. 10.1016/j.jtho.2018.05.027 (2018). DOI: 10.1016/j.jtho.2018.05.027"
                    },
                    {
                        "ref-fulltext": "Offin, M. et al. Acquired ALK and RET gene fusions as mechanisms of resistance to osimertinib in EGFR-mutant lung cancers. JCO Precis. Oncol. 10.1200/PO.18.00126 (2018). DOI: 10.1200/PO.18.00126",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Acquired ALK and RET gene fusions as mechanisms of resistance to osimertinib in EGFR-mutant lung cancers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1200/PO.18.00126",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR53",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85077486491",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Offin",
                                    "ce:indexed-name": "Offin M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JCO Precis. Oncol."
                        },
                        "ce:source-text": "Offin, M. et al. Acquired ALK and RET gene fusions as mechanisms of resistance to osimertinib in EGFR-mutant lung cancers. JCO Precis. Oncol. 10.1200/PO.18.00126 (2018). DOI: 10.1200/PO.18.00126"
                    },
                    {
                        "ref-fulltext": "Riester, M. et al. PureCN: Copy number calling and SNV classification using targeted short read sequencing. Source Code Biol. Med. 11, 13. 10.1186/s13029-016-0060-z (2016). DOI: 10.1186/s13029-016-0060-z",
                        "@id": "54",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "PureCN: Copy number calling and SNV classification using targeted short read sequencing"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s13029-016-0060-z",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR54",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85006152885",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {"@first": "13"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Riester",
                                    "ce:indexed-name": "Riester M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Source Code Biol. Med."
                        },
                        "ce:source-text": "Riester, M. et al. PureCN: Copy number calling and SNV classification using targeted short read sequencing. Source Code Biol. Med. 11, 13. 10.1186/s13029-016-0060-z (2016). DOI: 10.1186/s13029-016-0060-z"
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85124312940",
        "dc:description": "Despite the development of predictive biomarkers to shape treatment paradigms and outcomes, de novo EGFR TKI resistance advanced non-small cell lung cancer (NSCLC) remains an issue of concern. We explored clinical factors in 332 advanced NSCLC who received EGFR TKI and molecular characteristics through 65 whole exome sequencing of various EGFR TKI responses including; de novo (progression within 3 months), intermediate response (IRs) and long-term response (LTRs) (durability > 2 years). Uncommon EGFR mutation subtypes were significantly variable enriched in de novo resistance. The remaining sensitizing EGFR mutation subtypes (exon 19 del and L858R) accounted for 75% of de novo resistance. Genomic landscape analysis was conducted, focusing in 10 frequent oncogenic signaling pathways with functional contributions; cell cycle, Hippo, Myc, Notch, Nrf2, PI-3-Kinase/Akt, RTK-RAS, TGF-β, p53 and β-catenin/Wnt signaling. Cell cycle pathway was the only significant alteration pathway among groups with the FDR p-value of 6 × 10\u20134. We found only significant q-values of < 0.05 in 7 gene alterations; CDK6, CCNE1, CDK4, CCND3, MET, FGFR4 and HRAS which enrich in de novo resistance [range 36\u201373%] compared to IRs/LTRs [range 4\u201322%]. Amplification of CDK4/6 was significant in de novo resistance, contrary to IRs and LTRs (91%, 27.9% and 0%, respectively). The presence of co-occurrence CDK4/6 amplification correlated with poor disease outcome with HR of progression-free survival of 3.63 [95% CI 1.80\u20137.31, p-value < 0.001]. The presence of CDK4/6 amplification in pretreatment specimen serves as a predictive biomarker for de novo resistance in sensitizing EGFR mutation.",
        "pubmed-id": "35140316",
        "prism:coverDate": "2022-12-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85124312940",
        "dc:creator": {"author": [{
            "ce:given-name": "Piyada",
            "preferred-name": {
                "ce:given-name": "Piyada",
                "ce:initials": "P.",
                "ce:surname": "Sitthideatphaiboon",
                "ce:indexed-name": "Sitthideatphaiboon P."
            },
            "@seq": "1",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Sitthideatphaiboon",
            "@auid": "57192833487",
            "author-url": "https://api.elsevier.com/content/author/author_id/57192833487",
            "ce:indexed-name": "Sitthideatphaiboon P."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85124312940"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85124312940&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85124312940&origin=inward"
            }
        ],
        "source-id": "21100200805",
        "citedby-count": "11",
        "prism:volume": "12",
        "subtype": "ar",
        "dc:title": "Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer",
        "openaccess": "1",
        "prism:issn": "20452322",
        "publishercopyright": "© 2022, The Author(s).",
        "article-number": "2167",
        "prism:issueIdentifier": "1",
        "subtypeDescription": "Article",
        "prism:publicationName": "Scientific Reports",
        "openaccessFlag": "true",
        "prism:doi": "10.1038/s41598-022-06239-y",
        "dc:identifier": "SCOPUS_ID:85124312940",
        "dc:publisher": "Nature Research"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antineoplastic Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Biomarkers",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Carcinoma, Non-Small-Cell Lung",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Cyclin-Dependent Kinase 4",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Cyclin-Dependent Kinase 6",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Drug Resistance, Neoplasm",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "ErbB Receptors",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Gene Amplification",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Genes, erbB-1",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Lung Neoplasms",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Progression-Free Survival",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Protein Kinase Inhibitors",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Treatment Outcome",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Multidisciplinary",
        "@code": "1000",
        "@abbrev": "MULT"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Piyada",
            "preferred-name": {
                "ce:given-name": "Piyada",
                "ce:initials": "P.",
                "ce:surname": "Sitthideatphaiboon",
                "ce:indexed-name": "Sitthideatphaiboon P."
            },
            "@seq": "1",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Sitthideatphaiboon",
            "@auid": "57192833487",
            "author-url": "https://api.elsevier.com/content/author/author_id/57192833487",
            "ce:indexed-name": "Sitthideatphaiboon P."
        },
        {
            "ce:given-name": "Chinachote",
            "preferred-name": {
                "ce:given-name": "Chinachote",
                "ce:initials": "C.",
                "ce:surname": "Teerapakpinyo",
                "ce:indexed-name": "Teerapakpinyo C."
            },
            "@seq": "2",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Teerapakpinyo",
            "@auid": "56653456600",
            "author-url": "https://api.elsevier.com/content/author/author_id/56653456600",
            "ce:indexed-name": "Teerapakpinyo C."
        },
        {
            "ce:given-name": "Krittiya",
            "preferred-name": {
                "ce:given-name": "Krittiya",
                "ce:initials": "K.",
                "ce:surname": "Korphaisarn",
                "ce:indexed-name": "Korphaisarn K."
            },
            "@seq": "3",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199575",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"
            },
            "ce:surname": "Korphaisarn",
            "@auid": "56461382100",
            "author-url": "https://api.elsevier.com/content/author/author_id/56461382100",
            "ce:indexed-name": "Korphaisarn K."
        },
        {
            "ce:given-name": "Nophol",
            "preferred-name": {
                "ce:given-name": "Nophol",
                "ce:initials": "N.",
                "ce:surname": "Leelayuwatanakul",
                "ce:indexed-name": "Leelayuwatanakul N."
            },
            "@seq": "4",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Leelayuwatanakul",
            "@auid": "57201374781",
            "author-url": "https://api.elsevier.com/content/author/author_id/57201374781",
            "ce:indexed-name": "Leelayuwatanakul N."
        },
        {
            "ce:given-name": "Nopporn",
            "preferred-name": {
                "ce:given-name": "Nopporn",
                "ce:initials": "N.",
                "ce:surname": "Pornpatrananrak",
                "ce:indexed-name": "Pornpatrananrak N."
            },
            "@seq": "5",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Pornpatrananrak",
            "@auid": "57446072500",
            "author-url": "https://api.elsevier.com/content/author/author_id/57446072500",
            "ce:indexed-name": "Pornpatrananrak N."
        },
        {
            "ce:given-name": "Naravat",
            "preferred-name": {
                "ce:given-name": "Naravat",
                "ce:initials": "N.",
                "ce:surname": "Poungvarin",
                "ce:indexed-name": "Poungvarin N."
            },
            "@seq": "6",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199575",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"
            },
            "ce:surname": "Poungvarin",
            "@auid": "7005666704",
            "author-url": "https://api.elsevier.com/content/author/author_id/7005666704",
            "ce:indexed-name": "Poungvarin N."
        },
        {
            "ce:given-name": "Poonchavist",
            "preferred-name": {
                "ce:given-name": "Poonchavist",
                "ce:initials": "P.",
                "ce:surname": "Chantranuwat",
                "ce:indexed-name": "Chantranuwat P."
            },
            "@seq": "7",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Chantranuwat",
            "@auid": "36573266400",
            "author-url": "https://api.elsevier.com/content/author/author_id/36573266400",
            "ce:indexed-name": "Chantranuwat P."
        },
        {
            "ce:given-name": "Shanop",
            "preferred-name": {
                "ce:given-name": "Shanop",
                "ce:initials": "S.",
                "ce:surname": "Shuangshoti",
                "ce:indexed-name": "Shuangshoti S."
            },
            "@seq": "8",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60022183",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
                },
                {
                    "@id": "60022183",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
                }
            ],
            "ce:surname": "Shuangshoti",
            "@auid": "55063064300",
            "author-url": "https://api.elsevier.com/content/author/author_id/55063064300",
            "ce:indexed-name": "Shuangshoti S."
        },
        {
            "ce:given-name": "Chatchawit",
            "preferred-name": {
                "ce:given-name": "Chatchawit",
                "ce:initials": "C.",
                "ce:surname": "Aporntewan",
                "ce:indexed-name": "Aporntewan C."
            },
            "@seq": "9",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Aporntewan",
            "@auid": "9335314400",
            "author-url": "https://api.elsevier.com/content/author/author_id/9335314400",
            "ce:indexed-name": "Aporntewan C."
        },
        {
            "ce:given-name": "Wariya",
            "preferred-name": {
                "ce:given-name": "Wariya",
                "ce:initials": "W.",
                "ce:surname": "Chintanapakdee",
                "ce:indexed-name": "Chintanapakdee W."
            },
            "@seq": "10",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Chintanapakdee",
            "@auid": "57220047008",
            "author-url": "https://api.elsevier.com/content/author/author_id/57220047008",
            "ce:indexed-name": "Chintanapakdee W."
        },
        {
            "ce:given-name": "Virote",
            "preferred-name": {
                "ce:given-name": "Virote",
                "ce:initials": "V.",
                "ce:surname": "Sriuranpong",
                "ce:indexed-name": "Sriuranpong V."
            },
            "@seq": "11",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Sriuranpong",
            "@auid": "6603599644",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603599644",
            "ce:indexed-name": "Sriuranpong V."
        },
        {
            "ce:given-name": "Chanida",
            "preferred-name": {
                "ce:given-name": "Chanida",
                "ce:initials": "C.",
                "ce:surname": "Vinayanuwattikun",
                "ce:indexed-name": "Vinayanuwattikun C."
            },
            "@seq": "12",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Vinayanuwattikun",
            "@auid": "54390216800",
            "author-url": "https://api.elsevier.com/content/author/author_id/54390216800",
            "ce:indexed-name": "Vinayanuwattikun C."
        }
    ]}
}}